Elanco Animal Health Incorporated Receivables Turnover Ratio (ELAN), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Elanco Animal Health Incorporated  (NYSE: ELAN)
 

Elanco Animal Health Incorporated Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Elanco Animal Health Incorporated's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.78, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Elanco Animal Health Incorporated in Sep 30 2026 quarter, has decreased to 76 days, compared to 77 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 351 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2422, from overall ranking in the second quarter 2026 at 2651.

What is Receivable Turnover Ratio?
What is Elanco Animal Health Incorporated Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELAN Receivables Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Receivable Change 9.03 % 4.44 % 8.87 % 6.09 % 7.85 %
Y / Y Revenue Change 11.26 % 10.23 % 14.92 % 12.16 % 10.39 %
Receivable Turnover Ratio (TTM) 4.78 4.76 4.69 4.62 4.56
ELAN's Total Ranking # 2422 # 2651 # 2199 # 2089 #
Accounts Receivable average collection period days 76 77 78 79 80
Seq. Receivable Change -7.73 % -0.17 % 22.77 % -3.59 % -11.6 %
Seq. Revenue Change -7.53 % -0.22 % 19.84 % 0.62 % -8.38 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 352
Overall Market # 2422

Receivable Turnover Ratio Statistics
High Average Low
0.37 0.31 0.24
(Jun 30 2026)   (Dec 31 2020)





ELAN Company Profile • Back to ELAN Efficiency Comparisons • Compare ELAN Receivables Turnover Ratio to its Competitors

Financial Statements
Elanco Animal Health Incorporated's Accounts Receivable $ 1,063 Millions Visit ELAN's Balance sheet
Elanco Animal Health Incorporated's Sales TTM $ 5,148 Millions Visit ELAN's Income Statement
Sources of ELAN's Revenues Visit ELAN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ELAN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ELAN's Growth Rates ELAN's Roa ELAN's Inventory Turnover Ratio ELAN's Dividend Comparisons
ELAN's Profitability Ratios ELAN's Roi ELAN's Asset Turnover Ratio ELAN's Dividend Growth
ELAN's Valuation Ratios ELAN's Roe ELAN's Financial Strength Ratios ELAN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions
Quest Diagnostics Inc  7.43 $ 11,841.000  Millions$ 1,593.250  Millions

Date modified: 2026-11-07T13:23:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.